Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer

about

Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer

Item

http://www.wikidata.org/entity/Q58767976

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Immune checkpoint inhibitor re ...... ced non-small cell lung cancer

@en

Immune checkpoint inhibitor re ...... ced non-small cell lung cancer

@nl

type

Item

label

Immune checkpoint inhibitor re ...... ced non-small cell lung cancer

@en

Immune checkpoint inhibitor re ...... ced non-small cell lung cancer

@nl

prefLabel

Immune checkpoint inhibitor re ...... ced non-small cell lung cancer

@en

Immune checkpoint inhibitor re ...... ced non-small cell lung cancer

@nl

P1476

Immune checkpoint inhibitor re ...... ced non-small cell lung cancer

@en

P2093

Aya Nakaya

http://www.w3.org/2001/XMLSchema#string

Hiroshige Yoshioka

http://www.w3.org/2001/XMLSchema#string

Kayoko Kibata

http://www.w3.org/2001/XMLSchema#string

Maiko Niki

http://www.w3.org/2001/XMLSchema#string

Makoto Ogata

http://www.w3.org/2001/XMLSchema#string

Shosaku Nomura

http://www.w3.org/2001/XMLSchema#string

Takayasu Kurata

http://www.w3.org/2001/XMLSchema#string

Toshihiko Kaneda

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

Calreticulin exposure dictates the immunogenicity of cancer cell death

Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

Immunomodulatory effects of cyclophosphamide and implementations for vaccine design.

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer.

Classifying Cancers Based on T-cell Infiltration and PD-L1.

P304

32298-32304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25949

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30190787

http://www.w3.org/2001/XMLSchema#string

P932

6122346

http://www.w3.org/2001/XMLSchema#string